Literature DB >> 6625647

Is chemotactic activity of polymorphonuclear leukocytes increased in psoriasis?

A Langner, T P Chorzelski, M Fraczykowska, S Jabłońska.   

Abstract

Chemotactic activity of PMNs of 44 patients with common psoriasis and 20 healthy individuals was studied by modified Boyden chamber assay and casein as a chemoattractant. The patients were classified according to the activity of the disease, extent of skin lesions, and duration of the disease and of the last relapse. There was a high statistically significant increase in chemotactic response of the PMNs of psoriatics as compared with controls. The increase in chemotactic activity correlated positively with the activity of the disease but not with the extent of skin lesions. Very low values in some patients with longlasting and/or extensive lesions could depend upon the presence of inhibitory factors in plasma. The possible explanation for divergent results obtained by other authors could be due to the fact that various clinical parameters were not taken into account.

Entities:  

Mesh:

Year:  1983        PMID: 6625647     DOI: 10.1007/bf00416665

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  17 in total

1.  Psoriasiform eruption induced by propranolol.

Authors:  S Halevy; E J Feuerman
Journal:  Cutis       Date:  1979-07

Review 2.  Chemotaxis in cutaneous disease.

Authors:  M V Dahl
Journal:  Int J Dermatol       Date:  1978-03       Impact factor: 2.736

3.  The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles.

Authors:  P M Henson
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

4.  Inflammatory and immune cell function in psoriasis--a subtle disorder I. In vivo and in vitro survey.

Authors:  G G Krueger; H R Hill; W W Jederberg
Journal:  J Invest Dermatol       Date:  1978-09       Impact factor: 8.551

5.  Neutrophil chemotaxis in psoriasis.

Authors:  A Wahba; H Cohen; M Bar-Eli; R Callily
Journal:  Acta Derm Venereol       Date:  1979       Impact factor: 4.437

6.  Prostaglandins and chemotaxis: enhancement of polymorphonuclear leukocyte chemotaxis by prostaglandin F2alpha.

Authors:  J L Diaz-Perez; M E Goldyne; R K Winkelmann
Journal:  J Invest Dermatol       Date:  1976-03       Impact factor: 8.551

7.  Characterization of a leukotactic factor derived from psoriatic scale.

Authors:  H Tagami; S Ofuji
Journal:  Br J Dermatol       Date:  1977-11       Impact factor: 9.302

8.  Generalized pustular psoriasis precipitated by lithium carbonate.

Authors:  N J Lowe; H B Ridgway
Journal:  Arch Dermatol       Date:  1978-12

9.  Increased granulocyte adherence in psoriasis and psoriatic arthritis.

Authors:  J B Sedgwick; P R Bergstresser; E R Hurd
Journal:  J Invest Dermatol       Date:  1980-02       Impact factor: 8.551

10.  Suppression of leukocyte chemotaxis by human IgA myeloma components.

Authors:  D E Van Epps; R C Williams
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  5 in total

1.  Studies of polymorphonuclear migration into psoriatic skin using a new in vivo method.

Authors:  B Guillot; M Coupe; M Alirezai; J P Bureau; J J Guilhou
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

2.  Decreased extracellular release of granule enzymes from in vitro-stimulated polymorphonuclear leukocytes in guttate psoriasis.

Authors:  W Glinski; M Tigalonowa; S Jablonska; E Janczura
Journal:  Inflammation       Date:  1986-06       Impact factor: 4.092

3.  Defective natural-killer- and killer-cell activity associated with increased polymorphonuclear leukocyte adherence in psoriasis.

Authors:  S Majewski; M Wasik; S Jabłońska; M Kamiński; M Fraczykowska
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

4.  Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis.

Authors:  A Lundin; L Håkansson; G Michaëlsson; P Venge
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

5.  Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis.

Authors:  R E Schopf; J Höcher; M Rehder; L Färber; B Morsches
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.